WallStreetZenWallStreetZen

NASDAQ: ALGS
Aligos Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Aligos Therapeutics revenue was $4.71M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $2.8M, up 1,574.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ALGS annual revenue was $2.2M, with -44.6% growth year-over-year.

ALGS past revenue growth

How has ALGS's revenue growth performed historically?

Company
43.88%
Industry
238.67%
Market
37.91%
ALGS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ALGS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ALGS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ALGS revenue history

Current Revenue
$4.7M
Current Earnings
-$90.3M
Current Profit Margin
-1,919.7%

Be the first to know when ALGS announces revenue.

ALGS Revenue History By Year

ALGS Yearly RevenueALGS RevenueALGS ChangeALGS Revenue Growth
2025-12-31$2.19M-$1.76M-44.59%
2024-12-31$3.95M-$11.58M-74.60%
2023-12-31$15.53M$1.62M+11.66%
2022-12-31$13.91M$9.55M+219.04%
2021-12-31$4.36MN/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A

1 of 1

Aligos Therapeutics Revenue FAQ

What was ALGS's revenue last quarter?

Aligos Therapeutics (NASDAQ: ALGS) reported Q1 2026 revenue of $2.83 million up 809.97% year over year. In the same quarter last year, Aligos Therapeutics's revenue was $311.00 thousand.

What was Aligos Therapeutics's revenue in 2025?

Aligos Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $2.19 million, a 44.59% decrease year over year.

How much does Aligos Therapeutics make in a day?

Based on Aligos Therapeutics annual revenue for the past five years, ALGS makes an average of $21,877.26 per day.

What was Aligos Therapeutics's annual revenue growth in the past year?

As of Q2 2026, Aligos Therapeutics's revenue has grown 43.88% year over year. This is 194.78 percentage points lower than the US Biotechnology industry revenue growth rate of 238.67%. Aligos Therapeutics's revenue in the past year totaled $4.71 million.

How much does Aligos Therapeutics make in a year?

Aligos Therapeutics's revenue by year for the past five years is:
  • Aligos Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $2.19 million, a 44.59% decrease year over year.
  • Aligos Therapeutics's annual revenue for Dec 31, 2024 was $3.95 million, a 74.6% decrease from 2023.
  • Aligos Therapeutics's annual revenue for 2023 was $15.53 million, a 11.66% increase from 2022.
  • Aligos Therapeutics's annual revenue for 2022 was $13.91 million, a 219.04% increase from 2021.
  • Aligos Therapeutics's annual revenue for 2021 was $4.36 million, a Infinity% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.